(Q38214798)

31 August 2017

Polyunsaturated fatty acids in emerging psychosis: a safer alternative? (English)

1 reference

31 August 2017

0 references

1 reference

4

Paolo Fusar-Poli

0 references

Nilufar Mossaheb

object named as

Nilufar Mossaheb

8

0 references

Stefan Smesny

5

object named as

Stefan Smesny

1 reference

31 August 2017

Monika Schlögelhofer

1

1 reference

31 August 2017

G Paul Amminger

2

1 reference

31 August 2017

Miriam R Schaefer

3

1 reference

31 August 2017

Pat McGorry

6

1 reference

31 August 2017

Gregor Berger

7

1 reference

31 August 2017

27 May 2014

1 reference

Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders

31 August 2017

1 reference

31 August 2017

8

1 reference

31 August 2017

3

1 reference

31 August 2017

199-208

1 reference

Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review

31 August 2017

1 reference

The initial prodrome in psychosis: descriptive and qualitative aspects.

21 January 2018

1 reference

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

21 January 2018

1 reference

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

21 January 2018

1 reference

Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk

21 January 2018

1 reference

At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk

21 January 2018

1 reference

Cognitive functioning in prodromal psychosis: a meta-analysis

21 January 2018

1 reference

Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis.

21 January 2018

1 reference

Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies

21 January 2018

1 reference

Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.

21 January 2018

1 reference

Neuroimaging predictors of transition to psychosis--a systematic review and meta-analysis.

21 January 2018

1 reference

Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis

21 January 2018

1 reference

Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study

21 January 2018

1 reference

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis.

21 January 2018

1 reference

Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis.

21 January 2018

1 reference

Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies

21 January 2018

1 reference

Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.

21 January 2018

1 reference

Elevated striatal dopamine function linked to prodromal signs of schizophrenia

21 January 2018

1 reference

Functional neuroimaging in schizophrenia: diagnosis and drug discovery

21 January 2018

1 reference

Should attenuated psychosis syndrome be included in DSM-5?

21 January 2018

1 reference

Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

21 January 2018

1 reference

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

21 January 2018

1 reference

Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis

21 January 2018

1 reference

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

21 January 2018

1 reference

Early interventions to prevent psychosis: systematic review and meta-analysis

21 January 2018

1 reference

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

21 January 2018

1 reference

Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial

21 January 2018

1 reference

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

21 January 2018

1 reference

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

21 January 2018

1 reference

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

21 January 2018

1 reference

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

21 January 2018

1 reference

Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

21 January 2018

1 reference

The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia

21 January 2018

1 reference

Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia

21 January 2018

1 reference

Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study

21 January 2018

1 reference

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

21 January 2018

1 reference

The membrane hypothesis of schizophrenia

21 January 2018

1 reference

Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies

21 January 2018

1 reference

Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population

21 January 2018

1 reference

Anti-apoptotic role of omega-3-fatty acids in developing brain: perinatal hypothyroid rat cerebellum as apoptotic model.

21 January 2018

1 reference

Alteration and recovery of bleeding times, platelet aggregation and fatty acid composition of individual phospholipids in platelets of human subjects receiving a supplement of cod-liver oil

21 January 2018

1 reference

Expert opinion: omega-3 fatty acids and bleeding-cause for concern?

21 January 2018

1 reference

Omega-3 consumption and sudden cardiac death in schizophrenia.

21 January 2018

1 reference

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review

21 January 2018

1 reference

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives

21 January 2018

1 reference

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis.

21 January 2018

1 reference

Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review

21 January 2018

1 reference

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

21 January 2018

1 reference

Omega-3 fatty acids and sudden cardiac death in schizophrenia: if not a friend, at least a great colleague.

21 January 2018

1 reference

The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis

21 January 2018

1 reference

Oxidative stability of marine phospholipids in the liposomal form and their applications

21 January 2018

1 reference

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

Levels of PCDD/PCDFs and PCBs in edible marine species and human intake: a literature review

21 January 2018

1 reference

Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EIP.12151

1 reference

31 August 2017

1 reference